Pileblad E - Search Results

1

Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum.

Pileblad E, Magnusson T, Fornstedt B. Pileblad E, et al. J Neurochem. 1989 Mar;52(3):978-80. doi: 10.1111/j.1471-4159.1989.tb02550.x. J Neurochem. 1989. PMID: 2493072

2

Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat.

Bergquist F, Jonason J, Pileblad E, Nissbrandt H. Bergquist F, et al. Among authors: pileblad e. J Neurochem. 1998 Apr;70(4):1532-40. doi: 10.1046/j.1471-4159.1998.70041532.x. J Neurochem. 1998. PMID: 9523570

3

The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.

Snape BM, Pileblad E, Ekman A, Magnusson T, Carlsson A, Engel J. Snape BM, et al. Among authors: pileblad e. J Pharm Pharmacol. 1988 Sep;40(9):620-6. doi: 10.1111/j.2042-7158.1988.tb05321.x. J Pharm Pharmacol. 1988. PMID: 2907028

4

3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.

Elverfors A, Pileblad E, Lagerkvist S, Bergquist F, Jonason J, Nissbrandt H. Elverfors A, et al. Among authors: pileblad e. J Neurochem. 1997 Oct;69(4):1684-92. doi: 10.1046/j.1471-4159.1997.69041684.x. J Neurochem. 1997. PMID: 9326297

5

Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Pileblad E, Carlsson A. Pileblad E, et al. Pharmacol Toxicol. 1988 Apr;62(4):213-22. doi: 10.1111/j.1600-0773.1988.tb01875.x. Pharmacol Toxicol. 1988. PMID: 3260379

6

Marked reduction of rat brain glutathione following intracerebroventricular administration of the glutathione synthesis inhibitor L-buthionine sulfoximine.

Pileblad E, Magnusson T. Pileblad E, et al. Neurosci Lett. 1988 Dec 19;95(1-3):302-6. doi: 10.1016/0304-3940(88)90675-1. Neurosci Lett. 1988. PMID: 3226616 No abstract available.

7

Intracerebroventricular administration of L-buthionine sulfoximine: a method for depleting brain glutathione.

Pileblad E, Magnusson T. Pileblad E, et al. J Neurochem. 1989 Dec;53(6):1878-82. doi: 10.1111/j.1471-4159.1989.tb09256.x. J Neurochem. 1989. PMID: 2809598

8

In vivo autoxidation of dopamine in guinea pig striatum increases with age.

Fornstedt B, Pileblad E, Carlsson A. Fornstedt B, et al. Among authors: pileblad e. J Neurochem. 1990 Aug;55(2):655-9. doi: 10.1111/j.1471-4159.1990.tb04183.x. J Neurochem. 1990. PMID: 2370552

9

Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-one.

Pileblad E, Magnusson T. Pileblad E, et al. Life Sci. 1990;47(25):2333-42. doi: 10.1016/0024-3205(90)90272-s. Life Sci. 1990. PMID: 2263161

10

A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice.

Svensson A, Pileblad E, Carlsson M. Svensson A, et al. Among authors: pileblad e. J Neural Transm Gen Sect. 1991;85(2):117-29. doi: 10.1007/BF01244704. J Neural Transm Gen Sect. 1991. PMID: 1930876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results